SplicerAV: A tool for mining microarray expression data for changes in RNA processing

BMC Bioinformatics

Volumn 11, Issue , 2010, Pages

  Robinson, Timothy J ^a   Dinan, Michaela A ^b   Dewhirst, Mark ^a   Garcia Blanco, Mariano A ^a   Pearson, James L ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b University of North Carolina at Chapel Hill   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFFYMETRIX GENECHIP; BIOLOGICAL SAMPLES; EXPRESSION PROFILING; GENE EXPRESSION MICROARRAY; HUMAN MAMMARY EPITHELIAL CELLS; METALLOPROTEASE INHIBITORS; MICROARRAY DATA SETS; MICROARRAY EXPRESSIONS;

DATA REDUCTION; DISEASES; MICROARRAYS; PLANTS (BOTANY); RNA; TUMORS;

GENE EXPRESSION;

ISOPROTEIN; MESSENGER RNA; TUMOR MARKER;

ALGORITHM; ARTICLE; COMPUTER PROGRAM; DATA MINING; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETIC DATABASE; GENETICS; METABOLISM; METHODOLOGY; NEOPLASM;

ALGORITHMS; DATA MINING; DATABASES, GENETIC; GENE EXPRESSION PROFILING; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN ISOFORMS; RNA, MESSENGER; SOFTWARE; TUMOR MARKERS, BIOLOGICAL;

EID: 77950400895     PISSN: None     EISSN: 14712105     Source Type: Journal    
DOI: 10.1186/1471-2105-11-108     Document Type: Article

References (57)

1. Blencowe BJ. Alternative splicing: new insights from global analyses. Cell 2006, 126(1):37-47. 10.1016/j.cell.2006.06.023, 16839875.
2. Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C, Kingsmore SF, Schroth GP, Burge CB. Alternative isoform regulation in human tissue transcriptomes. Nature 2008, 456(7221):470-476. 10.1038/nature07509, 2593745, 18978772.
3. Krawczak M, Reiss J, Cooper DN. The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet 1992, 90(1-2):41-54. 10.1007/BF00210743, 1427786.
4. Lopez-Bigas N, Audit B, Ouzounis C, Parra G, Guigo R. Are splicing mutations the most frequent cause of hereditary disease?. FEBS Lett 2005, 579(9):1900-1903. 10.1016/j.febslet.2005.02.047, 15792793.
5. Garcia-Blanco MA, Baraniak AP, Lasda EL. Alternative splicing in disease and therapy. Nat Biotechnol 2004, 22(5):535-546. 10.1038/nbt964, 15122293.
6. Venables JP. Unbalanced alternative splicing and its significance in cancer. Bioessays 2006, 28(4):378-386. 10.1002/bies.20390, 16547952.
7. Cooper TA, Wan L, Dreyfuss G. RNA and disease. Cell 2009, 136(4):777-793. 10.1016/j.cell.2009.02.011, 19239895.
8. Takeda J, Suzuki Y, Nakao M, Barrero RA, Koyanagi KO, Jin L, Motono C, Hata H, Isogai T, Nagai K, et al. Large-scale identification and characterization of alternative splicing variants of human gene transcripts using 56,419 completely sequenced and manually annotated full-length cDNAs. Nucleic Acids Res 2006, 34(14):3917-3928. 10.1093/nar/gkl507, 1557807, 16914452.
9. Venables JP, Klinck R, Koh C, Gervais-Bird J, Bramard A, Inkel L, Durand M, Couture S, Froehlich U, Lapointe E, et al. Cancer-associated regulation of alternative splicing. Nat Struct Mol Biol 2009, 16(6):670-6. 10.1038/nsmb.1608, 19448617.
10. Xu Q, Lee C. Discovery of novel splice forms and functional analysis of cancer-specific alternative splicing in human expressed sequences. Nucleic Acids Res 2003, 31(19):5635-5643. 10.1093/nar/gkg786, 206480, 14500827.
11. He C, Zhou F, Zuo Z, Cheng H, Zhou R. A global view of cancer-specific transcript variants by subtractive transcriptome-wide analysis. PLoS ONE 2009, 4(3):e4732. 10.1371/journal.pone.0004732, 2648985, 19266097.
12. Andre F, Michiels S, Dessen P, Scott V, Suciu V, Uzan C, Lazar V, Lacroix L, Vassal G, Spielmann M, et al. Exonic expression profiling of breast cancer and benign lesions: a retrospective analysis. Lancet Oncol 2009, 10(4):381-390. 10.1016/S1470-2045(09)70024-5, 19249242.
13. Gardina PJ, Clark TA, Shimada B, Staples MK, Yang Q, Veitch J, Schweitzer A, Awad T, Sugnet C, Dee S, et al. Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array. BMC Genomics 2006, 7:325. 10.1186/1471-2164-7-325, 1769375, 17192196.
14. Xi L, Feber A, Gupta V, Wu M, Bergemann AD, Landreneau RJ, Litle VR, Pennathur A, Luketich JD, Godfrey TE. Whole genome exon arrays identify differential expression of alternatively spliced, cancer-related genes in lung cancer. Nucleic Acids Res 2008, 36(20):6535-6547. 10.1093/nar/gkn697, 2582617, 18927117.
15. Thorsen K, Sorensen KD, Brems-Eskildsen AS, Modin C, Gaustadnes M, Hein AM, Kruhoffer M, Laurberg S, Borre M, Wang K, et al. Alternative splicing in colon, bladder, and prostate cancer identified by exon array analysis. Mol Cell Proteomics 2008, 7(7):1214-1224. 10.1074/mcp.M700590-MCP200, 18353764.
16. Cheung HC, Baggerly KA, Tsavachidis S, Bachinski LL, Neubauer VL, Nixon TJ, Aldape KD, Cote GJ, Krahe R. Global analysis of aberrant pre-mRNA splicing in glioblastoma using exon expression arrays. BMC Genomics 2008, 9:216. 10.1186/1471-2164-9-216, 2410136, 18474104.
17. Laajala E, Aittokallio T, Lahesmaa R, Elo LL. Probe-level estimation improves the detection of differential splicing in Affymetrix exon array studies. Genome Biol 2009, 10(7):R77. 10.1186/gb-2009-10-7-r77, 2728531, 19607685.
18. Barrett T, Troup DB, Wilhite SE, Ledoux P, Rudnev D, Evangelista C, Kim IF, Soboleva A, Tomashevsky M, Marshall KA, et al. NCBI GEO: archive for high-throughput functional genomic data. Nucleic Acids Res 2009, (37 Database):D885-890. 10.1093/nar/gkn764, 2686538, 18940857.
19. Fodor SP, Rava RP, Huang XC, Pease AC, Holmes CP, Adams CL. Multiplexed biochemical assays with biological chips. Nature 1993, 364(6437):555-556. 10.1038/364555a0, 7687751.
20. Pearson JL, Robinson TJ, Munoz MJ, Kornblihtt AR, Garcia-Blanco MA. Identification of the cellular targets of the transcription factor TCERG1 reveals a prevalent role in mRNA processing. J Biol Chem 2008, 283(12):7949-7961. 10.1074/jbc.M709402200, 18187414.
21. Stalteri MA, Harrison AP. Interpretation of multiple probe sets mapping to the same gene in Affymetrix GeneChips. BMC Bioinformatics 2007, 8:13. 10.1186/1471-2105-8-13, 1784106, 17224057.
22. D'Mello V, Lee JY, MacDonald CC, Tian B. Alternative mRNA polyadenylation can potentially affect detection of gene expression by affymetrix genechip arrays. Appl Bioinformatics 2006, 5(4):249-253. 10.2165/00822942-200605040-00007, 17140271.
23. Bild AH, Yao G, Chang JT, Wang Q, Potti A, Chasse D, Joshi MB, Harpole D, Lancaster JM, Berchuck A, et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 2006, 439(7074):353-357. 10.1038/nature04296, 16273092.
24. Ferrari F, Bortoluzzi S, Coppe A, Sirota A, Safran M, Shmoish M, Ferrari S, Lancet D, Danieli GA, Bicciato S. Novel definition files for human GeneChips based on GeneAnnot. BMC Bioinformatics 2007, 8:446. 10.1186/1471-2105-8-446, 2216044, 18005434.
25. Lu J, Lee JC, Salit ML, Cam MC. Transcript-based redefinition of grouped oligonucleotide probe sets using AceView: high-resolution annotation for microarrays. BMC Bioinformatics 2007, 8:108. 10.1186/1471-2105-8-108, 1853115, 17394657.
26. Yu H, Wang F, Tu K, Xie L, Li YY, Li YX. Transcript-level annotation of Affymetrix probesets improves the interpretation of gene expression data. BMC Bioinformatics 2007, 8:194. 10.1186/1471-2105-8-194, 1913542, 17559689.
27. Warren P, Taylor D, Martini PGV, Jackson J, Bienkowska J. PANP - a New Method of Gene Detection on Oligonucleotide Expression Arrays. Proc 2007 IEEE 7th International Symposium on BioInformatics & BioEngineering, Cambridge, USA 2007, 108-115.
28. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, Haussler D. The human genome browser at UCSC. Genome Res 2002, 12(6):996-1006. 186604, 12045153.
29. Srinivasan K, Shiue L, Hayes JD, Centers R, Fitzwater S, Loewen R, Edmondson LR, Bryant J, Smith M, Rommelfanger C, et al. Detection and measurement of alternative splicing using splicing-sensitive microarrays. Methods 2005, 37(4):345-359. 10.1016/j.ymeth.2005.09.007, 16314264.
30. Neel H, Gondran P, Weil D, Dautry F. Regulation of pre-mRNA processing by src. Curr Biol 1995, 5(4):413-422. 10.1016/S0960-9822(95)00082-0, 7627556.
31. Chandler LA, Ehretsmann CP, Bourgeois S. A novel mechanism of Ha-ras oncogene action: regulation of fibronectin mRNA levels by a nuclear posttranscriptional event. Mol Cell Biol 1994, 14(5):3085-3093. 358676, 8164664.
32. Chandler LA, Bourgeois S. Posttranscriptional down-regulation of fibronectin in N-ras-transformed cells. Cell Growth Differ 1991, 2(8):379-384.
33. Darville MI, Rousseau GG. E2F-dependent mitogenic stimulation of the splicing of transcripts from an S phase-regulated gene. Nucleic Acids Res 1997, 25(14):2759-2765. 10.1093/nar/25.14.2759, 146819, 9207022.
34. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003, 4(2):249-264. 10.1093/biostatistics/4.2.249, 12925520.
35. Yao H, Xu L, Feng Y, Liu D, Chen Y, Wang J. Structure-function correlation of human programmed cell death 5 protein. Arch Biochem Biophys 2009, 486(2):141-149. 10.1016/j.abb.2009.03.018, 19358820.
36. Ullrich A, Coussens L, Hayflick JS, Dull TJ, Gray A, Tam AW, Lee J, Yarden Y, Libermann TA, Schlessinger J, et al. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature 1984, 309(5967):418-425. 10.1038/309418a0, 6328312.
37. Kashles O, Yarden Y, Fischer R, Ullrich A, Schlessinger J. A dominant negative mutation suppresses the function of normal epidermal growth factor receptors by heterodimerization. Mol Cell Biol 1991, 11(3):1454-1463. 369423, 1705006.
38. Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, Suyama A, Sugano S. Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library. Gene 1997, 200(1-2):149-156. 10.1016/S0378-1119(97)00411-3, 9373149.
39. Reiter JL, Threadgill DW, Eley GD, Strunk KE, Danielsen AJ, Sinclair CS, Pearsall RS, Green PJ, Yee D, Lampland AL, et al. Comparative genomic sequence analysis and isolation of human and mouse alternative EGFR transcripts encoding truncated receptor isoforms. Genomics 2001, 71(1):1-20. 10.1006/geno.2000.6341, 11161793.
40. Jaksik R, Polanska J, Herok R, Rzeszowska-Wolny J. Calculation of reliable transcript levels of annotated genes on the basis of multiple probe-sets in Affymetrix microarrays. Acta Biochim Pol 2009, 56(2):271-7.
41. Weiss GJ, Bemis LT, Nakajima E, Sugita M, Birks DK, Robinson WA, Varella-Garcia M, Bunn PA, Haney J, Helfrich BA, et al. EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines. Ann Oncol 2008, 19(6):1053-1059. 10.1093/annonc/mdn006, 18304967.
42. Sandberg R, Neilson JR, Sarma A, Sharp PA, Burge CB. Proliferating cells express mRNAs with shortened 3' untranslated regions and fewer microRNA target sites. Science 2008, 320(5883):1643-1647. 10.1126/science.1155390, 2587246, 18566288.
43. Basu A, Raghunath M, Bishayee S, Das M. Inhibition of tyrosine kinase activity of the epidermal growth factor (EGF) receptor by a truncated receptor form that binds to EGF: role for interreceptor interaction in kinase regulation. Mol Cell Biol 1989, 9(2):671-677. 362644, 2785240.
44. Adamson ED, Wiley LM. The EGFR gene family in embryonic cell activities. Curr Top Dev Biol 1997, 35:71-120. 10.1016/S0070-2153(08)60257-4, 9292268.
45. Browne BC, O'Brien N, Duffy MJ, Crown J, O'Donovan N. HER-2 signaling and inhibition in breast cancer. Curr Cancer Drug Targets 2009, 9(3):419-438. 10.2174/156800909788166484, 19442060.
46. Wan J, Sazani P, Kole R. Modification of HER2 pre-mRNA alternative splicing and its effects on breast cancer cells. Int J Cancer 2009, 124(4):772-777. 10.1002/ijc.24052, 2671679, 19035464.
47. Li C, Kato M, Shiue L, Shively JE, Ares M, Lin RJ. Cell type and culture condition-dependent alternative splicing in human breast cancer cells revealed by splicing-sensitive microarrays. Cancer Res 2006, 66(4):1990-1999. 10.1158/0008-5472.CAN-05-2593, 16488998.
48. Zhang C, Li HR, Fan JB, Wang-Rodriguez J, Downs T, Fu XD, Zhang MQ. Profiling alternatively spliced mRNA isoforms for prostate cancer classification. BMC Bioinformatics 2006, 7:202. 10.1186/1471-2105-7-202, 1458362, 16608523.
49. Sotiriou C, Pusztai L. Gene-expression signatures in breast cancer. N Engl J Med 2009, 360(8):790-800. 10.1056/NEJMra0801289, 19228622.
50. Loi S, Haibe-Kains B, Desmedt C, Wirapati P, Lallemand F, Tutt AM, Gillet C, Ellis P, Ryder K, Reid JF, et al. Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen. BMC Genomics 2008, 9:239. 10.1186/1471-2164-9-239, 2423197, 18498629.
51. Miller LD, Smeds J, George J, Vega VB, Vergara L, Ploner A, Pawitan Y, Hall P, Klaar S, Liu ET, et al. An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc Natl Acad Sci USA 2005, 102(38):13550-13555. 10.1073/pnas.0506230102, 1197273,1197273, 16141321.
52. Pawitan Y, Bjohle J, Amler L, Borg AL, Egyhazi S, Hall P, Han X, Holmberg L, Huang F, Klaar S, et al. Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts. Breast Cancer Res 2005, 7(6):R953-964. 10.1186/bcr1325, 1410752, 16280042.
53. Affymetrix Microarray Suite User Guide, Version 5. 2001, Affymetrix, Affymetrix., http://www.affymetrix.com/support/technical/manuals.affx
54. Fan W, Khalid N, Hallahan AR, Olson JM, Zhao LP. A statistical method for predicting splice variants between two groups of samples using GeneChip expression array data. Theor Biol Med Model 2006, 3:19. 10.1186/1742-4682-3-19, 1502129, 16603076.
55. Hu GK, Madore SJ, Moldover B, Jatkoe T, Balaban D, Thomas J, Wang Y. Predicting splice variant from DNA chip expression data. Genome Res 2001, 11(7):1237-1245. 10.1101/gr.165501, 311070, 11435406.
56. Thomas PD, Campbell MJ, Kejariwal A, Mi H, Karlak B, Daverman R, Diemer K, Muruganujan A, Narechania A. PANTHER: a library of protein families and subfamilies indexed by function. Genome Res 2003, 13(9):2129-2141. 10.1101/gr.772403, 403709, 12952881.
57. Thomas PD, Kejariwal A, Guo N, Mi H, Campbell MJ, Muruganujan A, Lazareva-Ulitsky B. Applications for protein sequence-function evolution data: mRNA/protein expression analysis and coding SNP scoring tools. Nucleic Acids Res 2006, (34 Web Server):W645-650. 10.1093/nar/gkl229, 1538848, 16912992.